Related Experiment Video
Updated: Jun 23, 2026

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
Malaria: severe, life-threatening
Aika Amy Anita Omari1, Paul Garner
1Glan Clwyd Hospital, Rhyl, Denbighshire, UK.
Insights
This systematic review examines antimalarial treatments for severe falciparum malaria. It found 31 studies on interventions like artemether and artesunate, assessing their effectiveness and safety.
Area of Science:
- Tropical medicine
- Infectious diseases
- Clinical pharmacology
Background:
- Severe malaria disproportionately impacts young children, non-immune travelers, and migrants.
- Cerebral malaria presents a high fatality rate (approx. 20%) and potential for neurological sequelae.
- Severe malarial anemia carries a significant mortality risk exceeding 13%.
Purpose of the Study:
- To systematically review the effects of antimalarial and adjunctive treatments for complicated falciparum malaria in non-pregnant individuals.
- To evaluate the effectiveness and safety of various interventions for severe malaria.
Main Methods:
- Conducted a systematic literature review up to December 2006, searching major databases (Medline, Embase, Cochrane Library).
- Included data from 31 systematic reviews, randomized controlled trials (RCTs), and observational studies.
- Incorporated safety alerts from regulatory agencies like the US FDA and UK MHRA.
Main Results:
- Identified 31 studies meeting inclusion criteria for the systematic review.
- Evaluated a range of interventions including dexamethasone, blood transfusions, intramuscular artemether, and intravenous artesunate.
Conclusions:
- The review synthesizes evidence on the effectiveness and safety of key interventions for severe malaria.
- Provides critical information for clinicians managing complicated falciparum malaria.
Introduction:
Severe malaria mainly affects children under 5 years old, non-immune travellers, migrants to malarial areas, and people living in areas with unstable or seasonal malaria. Cerebral malaria, causing encephalopathy and coma, is fatal in around 20% of children and adults, and neurological sequelae may occur in some survivors. Severe malarial anaemia may have a mortality rate of over 13%.
Methods And Outcomes:
We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of antimalarial treatments; and adjunctive treatment for complicated falciparum malaria in non-pregnant people? We searched: Medline, Embase, The Cochrane Library and other important databases up to December 2006 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Results:
We found 31 systematic reviews, RCTs, or observational studies that met our inclusion criteria.
Conclusions:
In this systematic review we present information relating to the effectiveness and safety of the following interventions: dexamethasone, exchange blood transfusion, initial blood transfusion, intramuscular artemether, intravenous artesunate.
Related Concept Videos
Malaria
Symbiosis
Rocky Mountain Spotted Fever
Bacterial Meningitis I: Introduction
Cryptococcal Meningitis
Yellow Fever

